5 Key Takeaways
-
1
Geographic atrophy (GA) care requires a continuous system of detection, referral, and treatment for optimal outcomes.
-
2
Recent FDA approvals of complement inhibitor therapies necessitate earlier detection and proactive referral for GA.
-
3
Optometrists and ophthalmologists are crucial in identifying GA early, ideally before foveal involvement, to influence treatment eligibility.
-
4
Optical coherence tomography (OCT) is essential for detecting early structural changes in GA, with dynamic review of scans being critical.
-
5
Early detection of GA is foundational to modern retinal care, emphasizing the need for refined imaging interpretation and collaboration.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.







